Contact PR

To use this feature, join Babbler easily !

Nice to see you again !

Download this content

Fill in this form and allow the PR contact who posted this content to identify you.

Invalid email address
Press release

Sanofi's Toujeo®
timer minutes reading time minute reading time

Copy link

Click to get original image size

Sanofi's Toujeo® met main objective in head-to-head study versus insulin degludec

Paris – December 4, 2017 – Sanofi’s Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi plans to provide full results in 2018. 

  • Health & Medicine
  • Medicine
  • Men's Health
  • Women's Health